Dermatology: Step-by-Step Guide on How to Write SOAP Notes

Updated January 2026

Dermatology documentation presents unique challenges that distinguish it from other medical specialties. The visual nature of skin conditions requires precise, standardized descriptive terminology that can accurately convey findings to other providers without requiring images. Effective dermatology SOAP notes must capture lesion morphology, distribution patterns, and clinical context while supporting diagnostic accuracy and treatment planning.

This guide provides comprehensive instructions for documenting dermatological encounters, from initial patient presentation through treatment outcomes. Whether you're evaluating a suspicious nevus, managing chronic psoriasis, or performing procedural dermatology, mastering dermatology-specific documentation will enhance patient care, support accurate coding, and ensure medical-legal protection.

Create Your Dermatology SOAP Note in 2 Minutes

Start with 20 free SOAP notes. No credit card required.

What Makes Dermatology Documentation Unique

Dermatology differs from other specialties in several key documentation aspects:

  1. Visual Documentation Dependency: Skin findings must be described with enough precision that another clinician could visualize the lesion without seeing it
  2. Standardized Morphological Terminology: Use of specific dermatological vocabulary (papule, plaque, macule, etc.) is essential
  3. Photography Integration: Clinical photography has become standard of care for many conditions
  4. Body Surface Area Calculations: Many conditions require BSA documentation for severity assessment and treatment decisions
  5. Procedural Documentation: High volume of biopsies, excisions, and cosmetic procedures require detailed documentation

Subjective Section (S)

In a dermatology SOAP note, the Subjective section captures the patient's description of their skin concern, relevant history, and symptom characteristics. This section provides critical context for clinical decision-making.

Subjective Section (S) Components

  1. Chief Complaint:

    • The primary skin concern bringing the patient to the visit
    • Example: "I have a new mole on my back that has been changing over the past three months."
  2. History of Present Illness (Lesion History):

    • Onset: When the lesion first appeared or was noticed
    • Duration: How long the condition has been present
    • Evolution: Changes in size, shape, color, or symptoms over time
    • Previous treatment: Prior therapies attempted and their outcomes
    • Example: "The patient noticed a small brown spot on the upper back approximately 6 months ago. Over the past 3 months, it has grown larger, developed irregular borders, and occasionally bleeds with minor trauma."
  3. Associated Symptoms:

    • Pruritus (itching): Severity (scale 0-10), timing, aggravating factors
    • Pain or tenderness: Character, intensity, triggers
    • Burning or stinging: Associated activities or exposures
    • Bleeding or drainage: Frequency, spontaneous vs. trauma-induced
    • Example: "The patient reports moderate itching (5/10) that worsens at night and with hot showers."
  4. Environmental and Exposure History:

    • Sun exposure history: Lifetime exposure, tanning bed use, sunburn history
    • Occupational exposures: Chemicals, irritants, outdoor work
    • Recent travel: Endemic dermatoses, new exposures
    • Contact history: New products, detergents, fragrances, metals
    • Example: "The patient has a history of significant sun exposure from outdoor work as a construction worker for 25 years, with multiple blistering sunburns in childhood."
  5. Skin Care Routine:

    • Current skincare products and frequency
    • Cleansers, moisturizers, prescription products
    • Recent changes in routine
    • Example: "Uses gentle fragrance-free cleanser daily, moisturizer twice daily. Recently started a new retinol product 2 weeks ago."
  6. Personal and Family Skin History:

    • Personal history of skin cancer or precancerous lesions
    • Family history of melanoma or other skin cancers
    • History of atypical moles or dysplastic nevus syndrome
    • Autoimmune conditions affecting skin
    • Example: "Father diagnosed with melanoma at age 55. Patient has history of multiple atypical nevi requiring monitoring."
  7. Review of Systems (Skin-Specific):

    • Hair changes: Loss, growth patterns, texture
    • Nail changes: Discoloration, thickening, separation
    • Mucous membrane involvement: Oral or genital lesions
    • Systemic symptoms: Fever, joint pain, fatigue (for inflammatory conditions)
    • Example: "Denies oral lesions, joint pain, or fever. Reports mild nail pitting on several fingernails."
  8. Allergies:

    • Known allergies to topical medications
    • Contact allergens previously identified
    • Drug allergies with reactions
    • Example: "Allergic to neomycin (contact dermatitis), penicillin (hives)."
  9. Current Medications:

    • Topical medications (prescription and OTC)
    • Systemic medications that may affect skin
    • Photosensitizing medications
    • Example: "Currently using hydrocortisone 1% cream PRN, takes hydrochlorothiazide 25mg daily for hypertension."

Tips for Dermatology Subjective Documentation:

  • Document the timeline of lesion evolution in detail
  • Record exact duration of symptoms when possible
  • Include relevant phototype/Fitzpatrick skin type
  • Note any photographic documentation obtained

Example of a Subjective Section for Dermatology

Subjective
 
 
The patient is a 58-year-old male (Fitzpatrick skin type II) presenting with a chief complaint of a changing mole on the upper back. The lesion was first noticed approximately 6 months ago as a small, flat, brown spot. Over the past 3 months, the patient has observed the spot growing larger, developing irregular borders, and darkening in color. The lesion occasionally bleeds with minor trauma from clothing friction. The patient denies pain or itching associated with the lesion.
 
Sun exposure history is significant for 25 years of outdoor work as a construction worker with multiple blistering sunburns during childhood and adolescence. The patient reports no history of tanning bed use. Family history is significant for father diagnosed with melanoma at age 55, successfully treated with excision.
 
Personal skin history includes multiple atypical nevi identified on previous full-body skin exams, with the last examination performed 18 months ago. The patient has no personal history of skin cancer.
 
Current medications include hydrochlorothiazide 25mg daily and aspirin 81mg daily. Allergies include neomycin (contact dermatitis). The patient uses daily sunscreen SPF 50 on face and hands but admits to inconsistent sun protection on the trunk.
 
The patient denies any new lesions elsewhere, nail changes, oral lesions, or systemic symptoms. The patient goal is to determine if this changing mole requires biopsy or removal.
 

Objective Section (O)

The Objective section in dermatology requires precise, standardized terminology to describe skin findings. Accurate documentation allows other providers to understand the clinical picture and is essential for appropriate coding and medical-legal protection.

Objective Section (O) Components

  1. Vital Signs (when relevant):

    • Blood pressure, heart rate (especially for procedures)
    • Temperature (for infectious or inflammatory conditions)
    • Example: "BP 128/82, HR 72, Temp 98.6F"
  2. General Appearance:

    • Overall skin health assessment
    • Fitzpatrick skin type documentation
    • General photodamage assessment
    • Example: "Well-appearing male with Fitzpatrick type II skin, moderate photodamage on sun-exposed areas."
  3. Primary Lesion Description: This is the core of dermatological documentation. Use the standardized approach:

    Morphology (Primary Lesion Type):

    • Macule: Flat, circumscribed color change under 1cm
    • Patch: Flat, circumscribed color change over 1cm
    • Papule: Elevated, solid lesion under 1cm
    • Plaque: Elevated, solid lesion over 1cm
    • Nodule: Palpable, solid lesion extending into dermis
    • Tumor: Large nodule over 2cm
    • Vesicle: Fluid-filled lesion under 1cm
    • Bulla: Fluid-filled lesion over 1cm
    • Pustule: Pus-filled lesion
    • Wheal: Transient, edematous papule or plaque

    Color:

    • Describe accurately: erythematous, hyperpigmented, hypopigmented, violaceous, brown, tan, black, pink, flesh-colored, white

    Size:

    • Measure in millimeters or centimeters
    • Use two dimensions for irregular lesions (e.g., 8mm x 6mm)

    Shape:

    • Round, oval, linear, annular, arcuate, serpiginous, irregular

    Border:

    • Well-defined, ill-defined, regular, irregular, notched

    Surface:

    • Smooth, rough, verrucous, scaly, crusted, ulcerated, eroded
  4. ABCDE Criteria for Pigmented Lesions: When evaluating melanocytic lesions, document each criterion:

    • A - Asymmetry: Is the lesion asymmetric in shape?
    • B - Border: Are borders irregular, notched, or scalloped?
    • C - Color: Is color uniform or variegated (multiple shades)?
    • D - Diameter: Is the lesion >6mm?
    • E - Evolution: Has the lesion changed over time?

    Example: "ABCDE assessment: Asymmetric (+), Borders irregular with notching (+), Color variegated with dark brown, light brown, and black areas (+), Diameter 9mm (+), Evolution with growth over 3 months per patient (+). 5/5 ABCDE criteria positive."

  5. Distribution and Configuration:

    Distribution Patterns:

    • Localized, generalized, symmetric, asymmetric
    • Sun-exposed areas, intertriginous, acral
    • Dermatomal, following Blaschko lines
    • Koebner phenomenon (if applicable)

    Configuration:

    • Discrete (individual lesions)
    • Grouped/clustered
    • Linear
    • Annular (ring-shaped)
    • Reticular (net-like)
    • Herpetiform
  6. Secondary Changes:

    • Scale, crust, erosion, ulceration
    • Excoriation, lichenification
    • Atrophy, scarring
    • Telangiectasia
  7. Dermoscopy Findings (when performed):

    • Document dermoscopic features observed
    • Pattern recognition findings
    • Specific structures (globules, dots, streaks, veil, network)
    • Example: "Dermoscopy reveals irregular pigment network, pseudopods at 3 and 7 o'clock positions, blue-white veil centrally, and atypical dots/globules."
  8. Body Surface Area (BSA) Assessment:

    • Required for conditions like psoriasis, atopic dermatitis, vitiligo
    • Rule of 9s or hand-as-1% method
    • Example: "Psoriatic plaques involving approximately 12% BSA: back 5%, bilateral lower extremities 4%, scalp 2%, elbows 1%."
  9. Photography Documentation:

    • Note when clinical photographs obtained
    • Location and number of images
    • Example: "Clinical photographs obtained: 2 overview images, 3 close-up images with ruler for scale, 2 dermoscopic images."
  10. Regional Lymph Node Examination:

    • Required for suspected malignancy
    • Example: "No palpable lymphadenopathy in cervical, axillary, or inguinal regions."

Lesion Description Framework Template

Lesion Description Template
 
 
LESION DESCRIPTION:
Location: [Anatomic site, laterality]
Number: [Single/multiple, approximate count if numerous]
Morphology: [Primary lesion type: macule, papule, plaque, nodule, etc.]
Size: [Dimensions in mm or cm]
Color: [Specific color description]
Shape: [Round, oval, irregular, etc.]
Border: [Well-defined, ill-defined, regular, irregular]
Surface: [Smooth, scaly, crusted, ulcerated, etc.]
Secondary changes: [Erosion, crust, scale, atrophy, etc.]
 
ABCDE Assessment (for pigmented lesions):
- Asymmetry: [Present/Absent]
- Border irregularity: [Present/Absent]
- Color variation: [Uniform/Variegated - list colors]
- Diameter: [<6mm / >6mm - exact measurement]
- Evolution: [Stable/Changing per patient history]
 
Distribution: [Localized/Generalized, pattern]
Configuration: [Discrete/Grouped/Linear/Annular/Other]
 
Dermoscopy (if performed): [Findings]
Photography: [Images obtained - number and type]
 

Example of an Objective Section for Dermatology

Objective
 
 
VITAL SIGNS: BP 130/78, HR 68, Temp 98.4F
 
GENERAL: Well-appearing 58-year-old male, Fitzpatrick skin type II, with moderate photodamage on face, neck, and dorsal hands.
 
SKIN EXAMINATION:
Primary Lesion of Concern:
- Location: Right upper back, inferior to right scapula
- Morphology: Asymmetric papule with surrounding macular component
- Size: 9mm x 7mm
- Color: Variegated - dark brown centrally, light brown peripherally, with focal area of blue-black pigmentation at 6 o'clock position
- Shape: Irregular, asymmetric
- Border: Irregular with notching at 2 and 8 o'clock positions
- Surface: Slightly raised centrally, smooth without ulceration or scale
 
ABCDE Assessment:
- A (Asymmetry): Positive - asymmetric in both axes
- B (Border): Positive - irregular, notched borders
- C (Color): Positive - 4 colors identified (dark brown, light brown, blue-black, tan)
- D (Diameter): Positive - 9mm (>6mm threshold)
- E (Evolution): Positive - documented growth and color change over 3 months
Assessment: 5/5 ABCDE criteria positive, concerning for melanoma
 
Dermoscopy Findings: Irregular pigment network with abrupt cutoff at periphery, blue-white veil over central portion, pseudopods at 3 and 7 o'clock, atypical dots and globules, regression structures (peppering) at 11 o'clock.
 
Additional Skin Findings:
- Multiple (>50) benign-appearing melanocytic nevi on trunk and extremities
- Several actinic keratoses on bilateral forearms and dorsal hands (approximately 6 lesions total)
- Moderate solar elastosis on posterior neck
 
LYMPH NODE EXAMINATION: No palpable lymphadenopathy in right axillary or cervical regions.
 
PHOTOGRAPHY: Clinical photographs obtained (2 overview, 3 close-up with scale, 2 dermoscopic images). Images stored in patient chart.
 

Assessment Section (A)

The Assessment section synthesizes subjective and objective findings to formulate a clinical impression and differential diagnosis. In dermatology, this section must justify the diagnostic approach and any procedures planned.

Assessment Section (A) Components

  1. Clinical Diagnosis/Impression:

    • Primary diagnosis or leading differential
    • Supporting clinical rationale
    • Example: "Atypical melanocytic lesion, concerning for malignant melanoma"
  2. Differential Diagnosis:

    • List alternative diagnoses considered
    • Rank by likelihood when possible
    • Example: "Differential includes: 1) Malignant melanoma, 2) Severely dysplastic nevus, 3) Pigmented basal cell carcinoma"
  3. Risk Assessment:

    • Patient risk factors for the suspected diagnosis
    • Risk stratification for skin cancer patients
    • Example: "High-risk for melanoma given family history, Fitzpatrick type II, significant sun exposure history, and multiple atypical nevi"
  4. Severity Assessment:

    • For chronic conditions: mild, moderate, severe
    • Validated scoring systems when applicable (PASI for psoriasis, EASI for atopic dermatitis, IGA)
    • Example: "Moderate plaque psoriasis, PASI score 8.2"
  5. Stage/Classification (when applicable):

    • Breslow depth and Clark level for melanoma
    • TNM staging when known
    • Example: "Pending histopathologic staging"
  6. Response to Previous Treatment:

    • Efficacy of prior therapies
    • Tolerance and adverse effects
    • Example: "Failed topical corticosteroids and topical calcineurin inhibitors, partial response to narrow-band UVB"
  7. Prognosis:

    • Expected disease course
    • Treatment expectations
    • Example: "Prognosis dependent on histopathologic findings; if melanoma confirmed, prognosis will depend on Breslow depth and staging"

Dermatological Diagnosis Approach

For systematic assessment, consider:

For Inflammatory Conditions:

  • Acute vs. chronic
  • Primary vs. secondary lesions
  • Distribution pattern suggesting diagnosis
  • Associated systemic features

For Neoplastic Conditions:

  • Benign vs. malignant features
  • Risk factors present
  • Need for tissue diagnosis
  • Staging requirements

For Infectious Conditions:

  • Bacterial, viral, fungal, parasitic
  • Culture/biopsy needs
  • Transmission considerations

Example of an Assessment Section for Dermatology

Assessment
 
 
CLINICAL IMPRESSION:
Atypical melanocytic lesion on right upper back, highly concerning for malignant melanoma
 
CLINICAL RATIONALE:
This lesion demonstrates 5/5 positive ABCDE criteria with dermoscopic features highly suggestive of melanoma, including irregular network, blue-white veil, pseudopods, and atypical dots/globules. The documented evolution with growth, color change, and new areas of blue-black pigmentation over a 3-month period further supports concern for malignancy.
 
DIFFERENTIAL DIAGNOSIS:
1. Malignant melanoma (most likely)
2. Severely dysplastic/atypical nevus
3. Pigmented basal cell carcinoma (less likely given dermoscopic features)
 
RISK FACTOR ASSESSMENT:
- Family history of melanoma (father)
- Fitzpatrick skin type II
- History of blistering sunburns
- Multiple atypical nevi (>50 melanocytic nevi on exam)
- Significant occupational UV exposure
Overall: HIGH RISK for melanoma
 
ADDITIONAL FINDINGS:
- Multiple actinic keratoses consistent with significant photodamage
- Continue monitoring of additional atypical nevi
 
INDICATION FOR BIOPSY:
Given the high clinical suspicion for melanoma based on ABCDE criteria, dermoscopic findings, and patient risk factors, excisional biopsy with narrow margins (1-3mm) is indicated for definitive histopathologic diagnosis.
 

Plan Section (P)

The Plan section outlines the diagnostic and treatment approach, patient education provided, and follow-up schedule. In dermatology, this often includes procedural documentation, detailed medication instructions, and lifestyle modifications.

Plan Section (P) Components

  1. Diagnostic Procedures:

    • Biopsy type and technique (shave, punch, excisional, incisional)
    • Specimen handling and pathology orders
    • Laboratory studies ordered
    • Example: "Excisional biopsy with 2mm clinical margins, specimen to dermatopathology for H&E and immunohistochemistry as indicated"
  2. Topical Medications:

    • Specific medication, strength, formulation (cream, ointment, solution, foam)
    • Application instructions (amount, frequency, duration, body areas)
    • Example: "Triamcinolone acetonide 0.1% ointment, apply thin layer to affected plaques on trunk and extremities twice daily for 2 weeks, then once daily for 2 weeks"
  3. Systemic Medications:

    • Oral, injectable, or biologic therapies
    • Dosing schedule and monitoring requirements
    • Example: "Methotrexate 15mg PO weekly, with folic acid 1mg daily. Baseline labs (CBC, CMP, hepatitis panel) today, repeat CBC and CMP in 2 weeks"
  4. Phototherapy:

    • Type (narrowband UVB, broadband UVB, PUVA)
    • Treatment schedule
    • Example: "Initiate narrowband UVB phototherapy, 3 times weekly, starting dose based on skin type"
  5. Procedural Plan:

    • Specific procedures planned
    • Anesthesia, technique, wound care instructions
    • Example: "Cryotherapy to 6 actinic keratoses on bilateral forearms using liquid nitrogen spray technique, two freeze-thaw cycles"
  6. Referrals:

    • Surgical oncology, plastic surgery, Mohs surgeon
    • Dermatopathology consultation
    • Other specialists as indicated
    • Example: "If melanoma confirmed, refer to surgical oncology for wide local excision and sentinel lymph node biopsy evaluation"
  7. Patient Education:

    • Disease information
    • Medication application techniques
    • Sun protection counseling
    • Skin self-examination instructions
    • Example: "Educated patient on ABCDE criteria for monthly skin self-examination. Counseled on sun protection including daily SPF 30+, protective clothing, and sun avoidance during peak hours"
  8. Follow-Up:

    • Timing of next appointment
    • Biopsy result communication plan
    • Monitoring schedule
    • Example: "Return in 7-10 days for suture removal and pathology review. Nurse will call with results if available sooner. If melanoma confirmed, urgent appointment for treatment planning"

Treatment Modality Categories in Dermatology

Topical Therapies:

  • Corticosteroids (low, medium, high, super-potent)
  • Calcineurin inhibitors
  • Retinoids
  • Antimicrobials
  • Antifungals
  • Immunomodulators

Procedural Therapies:

  • Biopsies (shave, punch, excisional, incisional)
  • Cryotherapy
  • Electrodesiccation and curettage
  • Excisions
  • Mohs micrographic surgery
  • Laser therapy
  • Photodynamic therapy

Phototherapy:

  • Narrowband UVB
  • Broadband UVB
  • PUVA
  • Excimer laser

Systemic Therapies:

  • Oral retinoids
  • Immunosuppressants
  • Biologics
  • Oral antibiotics
  • Antifungals
  • Antivirals

Example of a Plan Section for Dermatology

Plan
 
 
DIAGNOSTIC:
1. Excisional biopsy of right upper back lesion performed today under local anesthesia (1% lidocaine with epinephrine). Specimen excised with 2mm clinical margins, oriented with suture at 12 o'clock, placed in formalin, sent to dermatopathology with clinical history and dermoscopic images.
2. Request: H&E staining with melanocytic markers (S-100, HMB-45, Melan-A) as indicated by dermatopathologist.
 
WOUND CARE INSTRUCTIONS PROVIDED:
- Keep wound dry for 24 hours
- Clean daily with gentle soap and water after 24 hours
- Apply petroleum jelly and bandage daily
- Suture removal in 10-14 days
- Signs of infection reviewed (increasing redness, warmth, drainage, fever)
 
ADDITIONAL TREATMENTS:
1. Cryotherapy to 6 actinic keratoses on bilateral forearms - liquid nitrogen spray technique, two freeze-thaw cycles each. Expected course: blistering, crusting, healing over 2-3 weeks.
2. Actinic keratosis field therapy: Fluorouracil 5% cream, apply to bilateral forearms once daily for 2 weeks, then twice daily for 2 weeks (4-week course total). Expect redness, irritation, crusting - this indicates treatment is working.
 
PATIENT EDUCATION:
- Discussed concerning features of the biopsied lesion and the importance of histopathologic evaluation
- Reviewed potential diagnoses including melanoma
- Counseled extensively on sun protection: daily broad-spectrum SPF 50 to all exposed skin, reapply every 2 hours when outdoors, wear UPF-rated clothing, wide-brimmed hat, avoid peak sun (10am-4pm)
- Taught skin self-examination technique using ABCDE criteria - perform monthly
- Written instructions provided for all of the above
 
REFERRAL PLAN:
If pathology confirms melanoma:
- Urgent referral to surgical oncology for wide local excision discussion
- Sentinel lymph node biopsy evaluation if Breslow depth >1.0mm or high-risk features
- Multidisciplinary tumor board as indicated
 
FOLLOW-UP:
1. Phone call with pathology results expected in 5-7 business days
2. Return visit in 10-14 days for suture removal and detailed pathology review
3. Full-body skin examination in 6 months regardless of biopsy results given high-risk status
4. Annual dermatology visits for lifelong skin cancer surveillance
 
PRESCRIPTIONS:
1. Fluorouracil 5% cream, 40g tube, apply as directed above
2. Mupirocin 2% ointment, 22g tube, apply to biopsy site if signs of infection develop
 

AI-Assisted Documentation for Dermatology

AI-powered documentation tools are transforming dermatology practice, with 66% of healthcare providers now using AI in clinical settings. However, dermatology presents unique challenges and opportunities for AI-assisted documentation.

Benefits of AI Documentation in Dermatology

  • Standardized terminology: AI can ensure consistent use of dermatological vocabulary
  • Comprehensive lesion documentation: Prompts for complete lesion characterization
  • Efficiency gains: Reduced documentation time by up to 50-75%
  • Template integration: Automatic population of ABCDE criteria, BSA calculations

Dermatology-Specific AI Challenges

Image Integration Challenges:

  • Most AI scribes cannot directly interpret clinical photographs
  • Dermoscopic findings require verbal dictation for accurate capture
  • Photography documentation (number of images, types) must be explicitly stated
  • Image storage and EHR integration remain separate workflows

Lesion Description Accuracy:

  • Complex morphological descriptions may require verification
  • Multi-lesion documentation needs careful organization
  • Laterality and anatomic location require explicit confirmation
  • Size measurements should be stated clearly with units

What AI Captures Well in Dermatology:

  • Patient history and symptom timeline
  • Medication lists and allergy information
  • Sun exposure and risk factor history
  • Treatment plans and follow-up instructions
  • Patient education discussions

What Requires Careful Review:

  • Precise lesion measurements (verify exact numbers)
  • Color descriptions (confirm accuracy)
  • Anatomic locations (confirm laterality and specificity)
  • ABCDE criteria assessments (verify each criterion)
  • Dermoscopic findings (verify technical terminology)
  • Procedure documentation (confirm technique details)

Tips for Using AI with Dermatology Documentation

  1. State measurements explicitly: "The lesion measures nine millimeters by seven millimeters" rather than "about one centimeter"
  2. Dictate colors precisely: "Dark brown with areas of blue-black pigmentation" rather than "dark colored"
  3. Confirm anatomic locations: "Right upper back, inferior to the right scapula" rather than "upper back"
  4. Verbalize dermoscopy findings systematically: "Dermoscopy shows irregular pigment network, blue-white veil centrally, and pseudopods at three o'clock and seven o'clock positions"
  5. Review all objective findings carefully before signing AI-generated notes

AI and Photography in Dermatology

Current AI limitations with dermatology images:

  • AI scribes typically cannot analyze clinical photographs
  • Dermoscopic image interpretation requires specialized AI tools
  • Photography documentation is workflow-adjacent, not integrated
  • Verbal description remains essential for note accuracy

Best Practice: Dictate visual findings verbally while reviewing images, allowing AI to capture your clinical interpretation rather than relying on image analysis.

For more details, see our complete AI-Assisted Documentation Guide.

Telehealth Dermatology Documentation (Teledermatology)

Teledermatology has become an established practice modality, particularly for follow-up visits, medication management, and triage of new skin concerns. Per CMS 2026 guidelines, telehealth services continue to be covered with specific documentation requirements.

Teledermatology Modalities

Store-and-Forward (Asynchronous):

  • Patient or referring provider submits photographs for review
  • Dermatologist reviews images and provides consultation
  • No real-time interaction required
  • Documentation must note image quality and limitations

Live Interactive (Synchronous):

  • Real-time video consultation
  • Direct patient-provider interaction
  • Immediate feedback and discussion
  • Similar to in-person visit with visual limitations

Hybrid Models:

  • Combination of submitted images and video consultation
  • Often provides most comprehensive remote assessment

Photo Requirements for Teledermatology

Minimum Image Standards:

  • Good lighting (natural light preferred, avoid shadows)
  • In-focus images at appropriate distance
  • Multiple views (overview and close-up)
  • Reference for scale (ruler or coin if available)
  • Consistent background (solid, non-distracting)

Required Images:

  1. Overview image showing anatomic location
  2. Close-up image of lesion with scale reference
  3. Dermoscopic images when patient has dermatoscope or clinic-provided device

Telehealth-Specific Documentation Requirements

For virtual dermatology visits, document:

  1. Visit Logistics:

    • Telehealth modality (store-and-forward vs. live video)
    • Platform used (HIPAA-compliant)
    • Patient and provider locations (state for licensure)
    • Consent for telehealth services
  2. Image Quality Assessment:

    • Quality of photographs reviewed
    • Limitations due to image quality
    • Whether images were adequate for assessment
  3. Modified Physical Examination:

    • What could be assessed via video/photographs
    • What could not be assessed remotely
    • Palpation limitations clearly documented
  4. Telehealth Limitations Disclosure:

    • Clear statement of examination limitations
    • Recommendation for in-person follow-up if indicated
    • Conditions requiring in-person evaluation

Example Teledermatology Documentation - Store-and-Forward

Teledermatology Store-and-Forward Documentation
 
 
STORE-AND-FORWARD TELEDERMATOLOGY CONSULTATION
 
Referring Provider: [Name, credentials]
Referring Facility: [Clinic name, location]
Patient Location: [State]
Consulting Dermatologist Location: [State]
Date Images Submitted: [Date]
Date of Consultation: [Date]
 
IMAGES REVIEWED:
- 3 clinical photographs received
- Image quality: Good - adequate lighting, in-focus, scale reference present
- Views: 1 overview of left forearm, 2 close-up images of lesion with ruler
 
CLINICAL HISTORY PROVIDED:
58-year-old male with new lesion on left forearm, present for 6 weeks, slowly enlarging. Patient has history of basal cell carcinoma on nose (treated 2018). No symptoms of itching, bleeding, or pain reported.
 
ASSESSMENT BASED ON IMAGES:
Location: Left volar forearm, mid-forearm
Morphology: Pearly papule with visible telangiectasias
Size: Approximately 6mm per ruler reference
Color: Pink to flesh-colored with pearly quality
Border: Well-defined, slightly raised
Surface: Smooth, with central depression suggestive of early ulceration
 
CLINICAL IMPRESSION:
Basal cell carcinoma (nodular type), probable
Differential: Intradermal nevus, amelanotic melanoma (less likely)
 
LIMITATIONS OF TELEDERMATOLOGY ASSESSMENT:
- Unable to perform palpation to assess lesion texture and depth
- Unable to perform dermoscopy
- No dermatoscopic images available for review
- Assessment based on clinical photographs only
 
RECOMMENDATIONS:
1. In-person evaluation recommended for biopsy
2. Shave biopsy or punch biopsy indicated for tissue diagnosis
3. If confirmed BCC, discuss treatment options including electrodesiccation and curettage, excision, or Mohs surgery depending on location and histologic subtype
4. Recommend in-person appointment within 2-4 weeks
 
FOLLOW-UP:
Consultation sent to referring provider via secure message. Patient to schedule in-person dermatology appointment for biopsy. If unable to be seen within 4 weeks, please contact our office for expedited scheduling.
 

Example Teledermatology Documentation - Live Video

Teledermatology Live Video Documentation
 
 
TELEHEALTH SESSION DETAILS:
- Modality: Synchronous video visit
- Platform: [HIPAA-compliant platform name]
- Patient Location: Home in [State]
- Provider Location: Clinic in [State]
- Consent: Patient verbally consented to telehealth dermatology services
- Technical Quality: Good audio and video quality, adequate lighting at patient location
 
CHIEF COMPLAINT:
Follow-up for moderate plaque psoriasis on methotrexate therapy
 
SUBJECTIVE:
Patient reports improvement in psoriatic plaques since starting methotrexate 15mg weekly 8 weeks ago. Estimates 50% improvement in scaling and redness. Tolerating medication well without nausea, fatigue, or other side effects. Denies mouth sores, shortness of breath, or new symptoms. Folic acid 1mg daily as prescribed. Most recent labs 2 weeks ago were reviewed and within normal limits (CBC, CMP results in chart).
 
OBJECTIVE (Modified for Telehealth):
General: Patient appears well, in no acute distress
 
Skin Examination via Video:
- Bilateral elbows: Patient demonstrated plaques on video - appear improved from baseline photos, reduced scale, less erythema
- Bilateral knees: Patient demonstrated - similar improvement noted
- Scalp: Patient parted hair in multiple areas on video - scattered thin plaques, improved scaling
- Trunk: Patient lifted shirt for video examination - minimal residual plaques on lower back, significant improvement from baseline
 
BSA Estimate via Video: Approximately 3-4% (improved from 12% at baseline)
 
Video Examination Limitations:
- Lighting variable at patient location
- Unable to assess plaque thickness by palpation
- Scalp examination limited by hair coverage on video
- Color assessment may be affected by screen calibration
 
ASSESSMENT:
Moderate plaque psoriasis, improving on methotrexate therapy
- Approximately 70% improvement in BSA
- Good tolerability
- Labs stable
 
PLAN:
1. Continue methotrexate 15mg PO weekly
2. Continue folic acid 1mg daily
3. Labs: CBC, CMP in 6 weeks
4. Continue triamcinolone 0.1% ointment PRN for residual plaques
5. May consider dose optimization at next visit if further improvement desired
 
PATIENT EDUCATION:
- Reviewed importance of lab monitoring
- Discussed sun protection while on methotrexate
- Avoid alcohol
- Contact office for any new symptoms: mouth sores, persistent cough, easy bruising
 
FOLLOW-UP:
Telehealth follow-up in 8 weeks. In-person visit recommended every 6 months or sooner if concerns arise.
 
TELEHEALTH APPROPRIATENESS:
This follow-up visit was appropriate for telehealth given stable condition, established diagnosis, and patient's ability to demonstrate skin findings adequately via video. In-person examination recommended if new lesions develop, treatment changes needed, or patient unable to demonstrate adequate skin visualization.
 

For complete telehealth documentation guidance, see our Telehealth SOAP Notes Guide.

Free Dermatology SOAP Note Template

Speed up your documentation with our comprehensive dermatology SOAP note template. This template includes all essential elements for dermatological evaluations, lesion documentation, and treatment planning.

SOAP Note Template - Dermatology
 
SUBJECTIVE:
- Chief complaint: [Primary skin concern]
- History of present illness:
- Onset: [When lesion/condition first appeared]
- Duration: [How long present]
- Evolution: [Changes in size, shape, color, symptoms]
- Previous treatment: [Prior therapies and response]
- Associated symptoms:
- Pruritus: [Severity 0-10, timing, triggers]
- Pain/tenderness: [Character, severity]
- Bleeding/drainage: [Spontaneous vs. trauma-induced]
- Sun exposure history: [Lifetime exposure, sunburns, tanning bed use]
- Skin care routine: [Current products, recent changes]
- Personal skin history: [Previous skin cancers, atypical moles, conditions]
- Family history: [Melanoma, skin cancer, autoimmune skin conditions]
- Allergies: [Topical medications, contact allergens, drugs]
- Current medications: [Including topicals, photosensitizing drugs]
 
OBJECTIVE:
- Fitzpatrick skin type: [I-VI]
- General skin assessment: [Photodamage, overall condition]
 
Primary Lesion Description:
- Location: [Anatomic site, laterality]
- Number: [Single/multiple]
- Morphology: [Macule, papule, plaque, nodule, vesicle, etc.]
- Size: [Dimensions in mm/cm]
- Color: [Specific description]
- Shape: [Round, oval, irregular, etc.]
- Border: [Well-defined, irregular, notched]
- Surface: [Smooth, scaly, crusted, ulcerated]
- Secondary changes: [Erosion, crust, scale, atrophy]
 
ABCDE Assessment (for pigmented lesions):
- A (Asymmetry): [Present/Absent]
- B (Border irregularity): [Present/Absent]
- C (Color variation): [Uniform/Variegated - list colors]
- D (Diameter): [Measurement, >6mm or <6mm]
- E (Evolution): [Stable/Changing]
 
Distribution: [Pattern, body areas affected]
Configuration: [Discrete, grouped, linear, annular]
Dermoscopy findings: [If performed]
BSA involved: [Percentage, for inflammatory conditions]
Lymph node examination: [If indicated]
Photography: [Images obtained - type and number]
 
ASSESSMENT:
- Primary diagnosis: [Clinical impression]
- Differential diagnosis: [Alternative considerations]
- Risk factors: [Relevant patient factors]
- Severity/staging: [Mild/moderate/severe, PASI, other scores]
- Indication for biopsy: [If applicable]
 
PLAN:
1. Diagnostic procedures: [Biopsy type, labs ordered]
2. Topical medications: [Drug, strength, formulation, instructions]
3. Systemic medications: [Drug, dose, frequency, monitoring]
4. Procedural treatments: [Cryotherapy, excision, other]
5. Phototherapy: [Type, frequency if applicable]
6. Patient education: [Sun protection, skin self-exam, wound care]
7. Referrals: [Surgical oncology, Mohs, other specialists]
8. Follow-up: [Timing, purpose, biopsy result plan]

More Template Resources

Frequently Asked Questions

Document lesions systematically using standardized terminology: anatomic location with laterality, morphology (macule, papule, plaque, nodule, vesicle, etc.), size in millimeters, specific color description, shape (round, oval, irregular), border characteristics (well-defined, ill-defined, notched), surface features (smooth, scaly, crusted, ulcerated), and secondary changes (erosion, atrophy, lichenification). This standardized approach allows other providers to visualize the lesion without seeing it.

The ABCDE criteria are essential for melanoma evaluation: A-Asymmetry (is the lesion asymmetric in shape?), B-Border (are borders irregular, notched, or scalloped?), C-Color (is there color variation with multiple shades of brown, black, red, white, or blue?), D-Diameter (is the lesion greater than 6mm?), E-Evolution (has the lesion changed over time?). Document each criterion as present or absent with specific findings, and note the total number of positive criteria to support your clinical impression.

Document dermoscopy findings systematically including: the overall pattern (reticular, globular, homogeneous, starburst, multicomponent), specific structures observed (pigment network - regular or irregular, dots and globules, streaks/pseudopods, blue-white veil, regression structures, vascular patterns), and their locations using clock positions. Note whether dermoscopic images were captured and stored. Include your dermoscopic impression and how it supports your clinical diagnosis.

Document biopsy type (shave, punch, excisional, incisional), exact anatomic location, clinical indication, anesthesia used (type, concentration, with or without epinephrine), technique details, margin size if excisional, specimen handling (formalin, orientation sutures), wound closure method, and pathology orders including special stains requested. Include wound care instructions provided to the patient and your follow-up plan for results review.

Document BSA using the Rule of 9s (head 9%, each arm 9%, each leg 18%, trunk front 18%, trunk back 18%) or the patient's palm-as-1% method. List specific body areas involved with their percentage contribution. For example: 'Psoriatic plaques involving approximately 12% BSA: back 5%, bilateral lower extremities 4%, scalp 2%, elbows 1%.' BSA documentation is essential for treatment eligibility (biologics often require BSA greater than 10%), insurance authorization, and tracking treatment response over time.

For teledermatology, document: telehealth modality (store-and-forward or live video), HIPAA-compliant platform used, patient and provider locations, consent for telehealth services, and image quality assessment. Document what could be assessed (colors, patterns, distribution) and limitations (unable to palpate, no dermoscopy unless patient has device, color calibration limitations). Specify when in-person follow-up is needed for biopsy, dermoscopy, or lesions requiring hands-on evaluation.

Yes, SOAPNoteAI.com provides AI-assisted documentation that works well for dermatology practices. The platform is HIPAA-compliant with a signed Business Associate Agreement (BAA) and is available on iPhone, iPad, and web browsers. While AI scribes cannot directly interpret clinical photographs, they can capture verbally dictated lesion descriptions, ABCDE criteria, dermoscopy findings, treatment plans, and patient education. The tool helps standardize terminology and ensures comprehensive documentation across any medical specialty.

Medical Disclaimer: This content is for educational purposes only and should not replace professional medical judgment. Always consult current clinical guidelines and your institution's policies.

Was this page helpful?